Table 3 Concordance between the ADA/EASD and SED strategies in terms of patient classification
From: Meeting individualized glycemic targets in primary care patients with type 2 diabetes in Spain
SED | ||||
ADA/EASD | Low Risk (n(%)) | High Risk (n(%)) | Total (n(%)) | Pa,b |
Low Risk | 1517 (30.3) | 91 (1.8) | 1608 (32.1) | <0.0001 |
High Risk | 211 (4.2) | 3195 (63.7) | 3406 (67.9) | |
Total | 1728 (34.5) | 3286 (65.5) | 5014 (100) | |
SED + HYPO | ||||
ADA/EASD + HYPO | Low Risk (n(%)) | High Risk (n(%)) | Total (n(%)) | Pa,c |
Low Risk | 1395 (27.8) | 85 (1.7) | 1480 (29.5) | <0.0001 |
High Risk | 200 (4) | 3334 (66.5) | 3534 (70.5) | |
Total | 1595 (31.8) | 3419 (68.2) | 5014 (100) | |